Literature DB >> 25151022

Respiratory infections in patients undergoing mechanical ventilation.

Jordi Rello1, Thiago Lisboa2, Despoina Koulenti3.   

Abstract

Lower respiratory tract infections in mechanically ventilated patients are a frequent cause of antibiotic treatment in intensive-care units. These infections present as severe sepsis or septic shock with respiratory dysfunction in intubated patients. Purulent respiratory secretions are needed for diagnosis, but distinguishing between pneumonia and tracheobronchitis is not easy. Both presentations are associated with longlasting mechanical ventilation and extended intensive-care unit stay, providing a rationale for antibiotic treatment initiation. Differentiation of colonisers from true pathogens is difficult, and microbiological data show Staphylococcus aureus and Pseudomonas aeruginosa to be of great concern because of clinical outcomes and therapeutic challenges. Key management issues include identification of the pathogen, choice of initial empirical antibiotic, and decisions with regard to the resolution pattern.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25151022     DOI: 10.1016/S2213-2600(14)70171-7

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN: 2213-2600            Impact factor:   30.700


  21 in total

1.  What's new in ventilator-associated pneumonia?

Authors:  Jordi Rello; Jordi Riera; Ricardo Serrano
Journal:  Intensive Care Med       Date:  2015-06-11       Impact factor: 17.440

2.  Face and/or neck burns: a risk factor for respiratory infection?

Authors:  D Costa Santos; F Barros; N Gomes; T Guedes; M Maia
Journal:  Ann Burns Fire Disasters       Date:  2016-06-30

3.  IRF3 Inhibits Neutrophil Recruitment in Mice Infected with Pseudomonas aeruginosa.

Authors:  Zhenghao Piao; Haiying Yuan; Cuili Wang; Liyun Shi
Journal:  Inflammation       Date:  2017-06       Impact factor: 4.092

Review 4.  Management of the Patient with Chronic Critical Illness - Part 1: This is part one of a two part series. Part two will be published in September.

Authors:  Arkadiy Finn; Vijairam Selvaraj; Elijah Peterson; Debasree Banerjee; Amos Lal; Himmat Grewal; Edward Martin; Kwame Dapaah-Afriyie
Journal:  J Community Hosp Intern Med Perspect       Date:  2022-07-04

5.  The prophylactic effects of human IgG derived from sera containing high anti-PcrV titers against pneumonia-causing Pseudomonas aeruginosa.

Authors:  Mao Kinoshita; Hideya Kato; Hiroaki Yasumoto; Masaru Shimizu; Saeko Hamaoka; Yoshifumi Naito; Koichi Akiyama; Kiyoshi Moriyama; Teiji Sawa
Journal:  Hum Vaccin Immunother       Date:  2016-07-25       Impact factor: 3.452

Review 6.  Nosocomial pneumonia in 27 ICUs in Europe: perspectives from the EU-VAP/CAP study.

Authors:  D Koulenti; E Tsigou; J Rello
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-06-10       Impact factor: 3.267

Review 7.  Pseudomonas aeruginosa ventilator-associated pneumonia management.

Authors:  Sergio Ramírez-Estrada; Bárbara Borgatta; Jordi Rello
Journal:  Infect Drug Resist       Date:  2016-01-20       Impact factor: 4.003

8.  Hyperoxemia as a risk factor for ventilator-associated pneumonia.

Authors:  Sophie Six; Karim Jaffal; Geoffrey Ledoux; Emmanuelle Jaillette; Frédéric Wallet; Saad Nseir
Journal:  Crit Care       Date:  2016-06-22       Impact factor: 9.097

9.  Sequential Measurements of Pentraxin 3 Serum Levels in Patients with Ventilator-Associated Pneumonia: A Nested Case-Control Study.

Authors:  Huseyin Bilgin; Murat Haliloglu; Ali Yaman; Pinar Ay; Beliz Bilgili; Mustafa Kemal Arslantas; Filiz Ture Ozdemir; Goncagul Haklar; Ismail Cinel; Lutfiye Mulazimoglu
Journal:  Can J Infect Dis Med Microbiol       Date:  2018-05-13       Impact factor: 2.471

10.  Spectrum of pathogen- and model-specific histopathologies in mouse models of acute pneumonia.

Authors:  Kristina Dietert; Birgitt Gutbier; Sandra M Wienhold; Katrin Reppe; Xiaohui Jiang; Ling Yao; Catherine Chaput; Jan Naujoks; Markus Brack; Alexandra Kupke; Christin Peteranderl; Stephan Becker; Carolin von Lachner; Nelli Baal; Hortense Slevogt; Andreas C Hocke; Martin Witzenrath; Bastian Opitz; Susanne Herold; Holger Hackstein; Leif E Sander; Norbert Suttorp; Achim D Gruber
Journal:  PLoS One       Date:  2017-11-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.